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In October 2001, two envelopes containing Bacillus anthracis spores were processed at the Washington,
D.C., Processing and Distribution Center of the U.S. Postal Service; inhalational anthrax developed in four
workers at this facility. More than 2,000 workers were advised to complete 60 days of postexposure pro-
phylaxis to prevent inhalational anthrax. Interventions to promote adherence were carried out to support
workers, and qualitative information was collected to evaluate our interventions. A quantitative survey was
administered to a convenience sample of workers to assess factors influencing adherence. No anthrax
infections developed in any workers involved in the interventions or interviews. Of 245 workers, 98 (40%)
reported full adherence to prophylaxis, and 45 (18%) had completely discontinued it. Anxiety and experi-
encing adverse effects to prophylaxis, as well as being <45 years old were risk factors for discontinuing
prophylaxis. Interventions, especially frequent visits by public health staff, proved effective in supporting
adherence. 
n October 2001, two letters with Bacillus anthracis spores
were mailed to offices on Capitol Hill, Washington, D.C.
Both letters were processed at the Washington, D.C., Process-
ing and Distribution Center (DCPDC) of the U.S. Postal Ser-
vice (USPS). Inhalational anthrax developed in four DCPDC
postal workers; two died. More than 2,000 workers and busi-
ness visitors to the private work areas of DCPDC were poten-
tially exposed to aerosolized B. anthracis spores during
October 12–21 (1,2). To prevent inhalational anthrax, 60 days
of antimicrobial therapy was recommended (primary: ciprof-
loxacin 500 mg/orally twice a day or doxycycline 100 mg/
orally twice a day; alternative: amoxicillin 500 mg/orally
twice a day).
Although inhalational anthrax most often develops in the
first 7–10 days after exposure, incubation periods as long as 43
days have been reported in Sverdlovsk, Russia (3); in animal
studies, inhalational anthrax occurred after 58 days despite 30
days of antimicrobial therapy (4). Therefore, completion of the
full 60 days of prophylactic antimicrobial therapy was essen-
tial for all postal workers potentially exposed to B. anthracis
spores at the DCPDC. 
Adherence to long-term drug regimens is problematic, and
multiple factors influence adherence status, such as regimen
factors (e.g., number of pills needed daily), structural factors
(e.g., ability to access drugs), individual factors (e.g., cogni-
tive limitations, depression), and health-care provider factors
(e.g., ability to listen to and communicate effectively with
patients) (5–10). Among the DCPDC workers, typical adher-
ence issues associated with short-course antimicrobial therapy
were complicated by the high levels of stress associated with
the bioterrorism event and the illnesses and deaths of cowork-
ers, stigma from other postal workers and community mem-
bers because of erroneous concerns that DCPDC workers were
contagious, and the relatively longer duration and potential
adverse effects associated with the therapy. The DCPDC facil-
ity was closed October 21, 2001, and employees were dis-
placed to work in other area mail facilities, contributing to
ongoing disruptions of the workers’ daily lives and further
complicating adherence. Last, the dynamic nature of the biot-
errorist event created a system of evolving health-risk commu-
nication that, combined with the many inconsistent sources of
information about the event and anthrax, contributed to confu-
sion and misinformation.
In response to the first bioterrorism-related outbreak of
inhalational anthrax in the United States, strategies to promote
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adherence to antimicrobial prophylaxis among more than
2,000 DCPDC workers were rapidly implemented. To facili-
tate future adherence activities in similar events, we evaluated
the interventions that were used to support adherence and
examined the factors that influenced adherence to the prophy-
lactic regimen in DCPDC workers.
Methods
Qualitative Data Collection
Qualitative data were collected from open-ended inter-
views (i.e., ones in which interviewer writes down exact
responses of interviewee) with convenience samples of the
postal worker population throughout the 60-day period to
develop and evaluate the interventions and to collect informa-
tion on the determinants of adherence. The findings from the
qualitative interviews were used to develop and validate the
close-ended questions (i.e., those with a defined set of answers
to choose from, such as yes or no) included in the quantitative
survey questionnaire. Information was collected through
observation, one-on-one contact, informal small group discus-
sions, and focus group interviews with workers, as well as
through interactions with USPS management, worker union
representatives, and USPS Employee Assistance Program per-
sonnel. 
Two staff members from the Centers for Disease Control
and Prevention (CDC) conducted five focus group interviews
with DCPDC workers during December 13–16, 2001. DCPDC
shift supervisors selected six to eight workers to participate in
each focus group. During the interviews, workers’ responses
were noted verbatim on a large flip chart visible to participants
at all times. The first author also carried out individual qualita-
tive open-ended interviews during routine interactions with
workers throughout December 2001. 
The first author conducted all analyses. Notes were imme-
diately reviewed for accuracy at the completion of all inter-
views and entered into a word-processing software program.
Qualitative analysis included several rounds of coding by sub-
ject or theme, as well as content analysis and comparison of
responses across groups. Analysis focused on both commonly
repeated themes (reported by at least 50% of the respondents)
and rare points of view. 
Interventions to Promote Adherence
To develop appropriate adherence interventions, we
obtained support from the USPS management, Employee
Assistance Program, and postal service unions. We conducted
open-ended interviews with postal workers from various jobs
and shifts and incorporated known adherence strategies
(5,6,8,10,11) to develop interventions. 
Public health staff carried out repeated group question-
and-answer sessions and informal contact with workers. These
sessions consisted of large and small group and one-on-one
interactions to counsel workers. Motivational messages were
distributed through the USPS communication infrastructure. In
addition, several types of written materials were distributed at
the worksite and to workers’ homes, including booklets of fre-
quently asked questions about anthrax and antimicrobial ther-
apy, antimicrobial pocket guides with calendar memory aids,
and handouts describing ways to minimize stress and recog-
nize the known adverse effects of antimicrobial therapy, such
as gastrointestinal upset and yeast infection. Posters and table
tents, both with motivational messages, were placed in the
workplace. We also provided a letter for workers to take to
their personal health-care provider clarifying which area postal
workers needed extended prophylaxis and the recommended
regimens. This letter was also distributed directly to area
health-care providers. Further, after free antimicrobial agents
were no longer available, access to antimicrobial agents and
reimbursements was facilitated. Finally, clinical team mem-
bers and a local health-care provider answered specific ques-
tions about adverse effects or potential drug interactions, and
the local health-care provider consulted with workers free of
charge. 
In addition, multiple Morbidity and Mortality Weekly
Reports (12–14), Health Alert Network alerts, and live broad-
casts were disseminated throughout the prophylaxis period to
give health-care providers detailed information on which
groups needed extended prophylaxis, the recommended regi-
mens, and clinical signs of inhalational anthrax disease. 
Quantitative Survey
At five mail facilities, trained interviewers administered a
close-ended  questionnaire to a convenience sample of all
DCPDC employees working the day shift (7 a.m.–3 p.m.) on
December 18–20, 2001, days 57–60 of the 60-day regimen.
Prophylaxis was first offered October 21, 2001, and most
workers picked up prophylaxis on October 22 or 23, 2001.
Most (80%) of the displaced DCPDC employees worked at
these five facilities. Compared with the day shift, more
employees work the swing shift and night shift, when the mail
collected during the day is processed. 
The questionnaire collected information on demographic
characteristics, adherence behaviors, enablers and obstacles to
adherence, and information about the implementation of inter-
ventions. To assess adherence, workers were asked to respond
to five questions located throughout the survey. (For example,
“Are you still taking antibiotics for anthrax?” [Possible
responses: No, Yes, Declined] and “If you forgot to take any of
your pills yesterday, how many pills did you miss?” [Possible
responses: None, One, Two, Three.).
Because we were interested in adherence to the recommen-
dation to complete 60 days of prophylaxis, workers were
divided into one of three categories. Adherence was defined as
full if workers reported they continuously took their antimicro-
bial therapy throughout the 60-day period, never reduced their
dosage, and did not forget any pills the previous day. Adher-
ence was defined as intermediate if workers reduced the dos-
age, forgot a pill the previous day, or stopped their
antimicrobial therapy and restarted at least once. AdherenceBIOTERRORISM-RELATED ANTHRAX
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was defined as discontinued if workers stopped their antimi-
crobial therapy and never restarted. 
To analyze predictors of nonadherence, we carried out a
three-step logistic regression modeling procedure. First, we
modeled overall nonadherence (intermediate adherence and
discontinued groups combined) compared with full adherence.
For this model, we were interested in understanding the differ-
ences between those workers who were fully adherent and
those who were not fully adherent, including workers who
completely discontinued therapy. Second, we modeled inter-
mediate adherence compared with full adherence. For this
model, we were interested in understanding the differences
between those who were nonadherent but who had not com-
pletely discontinued therapy and those who were fully adher-
ent. Third, we modeled the discontinued group compared with
the full adherence group. For this model, we were interested in
assessing the differences between those who had completely
discontinued therapy and those who were fully adherent. 
Variables examined were based on previously published
articles on adherence and those associated with perceived risk
and potential exposure to B. anthracis spores in this setting.
Inhalational anthrax developed in employees who worked on a
sorter machine and in the government mail section of the
DCPDC (2). Variables included age, sex, race, perceived risk
of breathing in B. anthracis spores, work location during expo-
sure period, work description during the time of interview,
trouble remembering to take pills, experiencing anxiety, physi-
cal signs of stress, severity of adverse effects, and adverse
effects negatively affecting work performance. For all analy-
sis, SAS 8.2 (SAS Institute, Inc., Cary, NC) was used. For
univariate analysis, two-tailed p values were calculated by chi-
square test for dichotomous variables. Potential covariates for
the logistic regression models included those with p<0.20 in
univariate analysis, and possible confounders. We followed a
backward elimination strategy to remove nonsignificant cova-
riates in building final parsimonious models. A p<0.05 was
determined to be statistically significant.
For all qualitative and quantitative interviews, workers
were informed that their participation was voluntary and anon-
ymous. Anthrax infections did not develop in any of the work-
ers who participated in the interventions or interviews.
Results
Characteristics of Participants
Of 251 DCPDC workers invited to participate in the ques-
tionnaire, 245 (98%) agreed. Among participants, 124 (51%)
were male, and 214 (88%) identified themselves as black.
Only 1 (0.5%) worker was 18–24 years of age, 74 (30%) were
25–44 years, 163 (67%) were 45–64 years, and 6 (2%) were
>65 years of age. 
Comparison of Adherence among Workers
Among those who completed the questionnaire, 98 (40%)
reported full adherence, 45 (18%) discontinued prophylaxis
and never restarted, and 102 (42%) were classified as interme-
diate. Overall, 186 (76%) workers were taking prophylaxis at
the time of the interview, including 88 (86%) of the 102 classi-
fied as in the intermediate group. Among the intermediate
group, 14 (14%) reported discontinuing prophylaxis and
restarting at least once, but they were not taking antibiotics at
the time of the interview. A total of 45 workers from the dis-
continued group and 48 workers from the intermediate group
reported stopping prophylaxis.
Among the 102 workers classified as intermediate, 40
(39%) reported ever reducing the dosage, 65 (64%) forgot to
take at least one pill the previous day, and 48 (47%) reported
discontinuing prophylaxis and restarting at least once. Among
those who restarted, 20 (42%) missed at least one pill the pre-
vious day, and 22 (46%) reported they had ever reduced the
dosage.
We examined reasons for stopping prophylactic antimicro-
bial therapy (Table 1). Most workers reported that several fac-
tors influenced their decision to discontinue prophylaxis; 60%
cited five or more reasons. Trouble managing adverse effects
to antimicrobial agents was the most common reason. Concern
over possible long-term adverse effects associated with pro-
longed antimicrobial therapy was the second most common
Table 1. Reasons for stopping prophylaxis or reducing dosage during 
anthrax outbreak, Washington, D.C., 2001
Reasons for stopping prophylaxis (n=93)a n (%) 
Adverse effects 73 (78)
Potential long-term adverse effects 59 (63)
Low risk of developing anthrax disease 47 (51)
Concerns about antibiotic resistance 32 (34)
Negative environmental test results (facility or nasal) 28 (30)
Saving antibiotic for later use 25 (27)
Restrictions to diet or alcohol consumption 22 (24)
Lack of support at work 16 (17)
Difficulty getting appointment with health-care provider 9 (10)
Advised by health-care provider 7 (7)
Expense of health-care provider visit or antibiotic 6 (6)
Reasons for reducing dosage (n=53)b
Adverse effects 38 (72)
Potential long-term adverse effects 8 (15)
Advised by health-care provider 2 (4)
Difficulty remembering to take antibiotic 2 (4)
Take only on workdays 2 (4)
Low supply of pills  1 (2)
aWorkers were asked to respond to each reason. A total of 45 workers from the discon-
tinued group and 48 workers from the intermediate group reported stopping prophy-
laxis. 
bWorkers chose only answers that applied. A total of 13 workers from the discontinued 
group and 40 workers from the intermediate group reported reducing the dosage. 
Among the 53 workers who reduced their dosage, 5 reported more than one reason, and 
5 reported other reasons not included here.Emerging Infectious Diseases  •  Vol. 8, No. 10, October 2002 1141
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reason for stopping. Similar reasons were given by the work-
ers who reported reducing the dosage of the prescribed antimi-
crobial therapy. Workers who stopped therapy also reported
lacking sufficient information about anthrax and antimicrobial
therapy, specifically, information from USPS or CDC.
Predictors of Nonadherence
We wanted to understand the differences between those
who were not fully adherent, excluding those who completely
discontinued therapy, compared with those who were fully
adherent. We therefore modeled intermediate adherence com-
pared with full adherence. Characteristics of these populations
and univariate analysis are in Table 2. Independent predictors
of intermediate adherence included experiencing “a lot” of
adverse effects to antimicrobial therapy, trouble remembering
to take pills, as well as age <45 years (Table 3). Experiencing
“a lot” of adverse effects, trouble remembering to take pills,
and age <45 years were also risk factors for nonadherence in a
model combining the intermediate adherence and discontinued
groups compared with full adherence (data not shown).
We wanted to understand the differences between those
who completely discontinued therapy and those who were
fully adherent. We therefore modeled the discontinued group
compared with the full adherence group. Characteristics of
these populations and univariate analysis can be found in
Table 4. Independent predictors of discontinuing therapy
included experiencing “a lot” of adverse effects, anxiety, and
age <45 years (Table 5). Those workers who reported a high
perceived risk of having breathed in B. anthracis spores during
October 12–21, 2001, were significantly less likely to have
discontinued therapy. Those who experienced five or more
physical signs of stress were also significantly less likely to
have discontinued therapy.
Postal Workers’ Experiences 
and Qualitative Evaluation of Interventions
A total of 38 workers participated in five focus groups, and
22 participated in individual qualitative interviews. The age,
sex, and race/ethnic characteristics of qualitative interview
participants were similar to those of respondents to the survey
questionnaire. 
When asked in focus groups and individual qualitative
interviews about what adherence interventions were helpful,
workers consistently cited repeated visits by public health staff
to worksites. Workers reported that the ability to ask personal
questions and the distribution of various materials covering
multiple health- and work-related issues helped workers com-
plete prophylaxis and promoted adherence by providing accu-
rate and needed information about anthrax, antimicrobial
therapy, risk for disease, and the outbreak investigation. Work-
ers reported that this information helped reduce their stress
levels and motivated them to continue prophylaxis. 
Workers recalled receiving little information at the free
antimicrobial distribution sites, and some had forgotten or mis-
understood the initial information given. Several opportunities
Table 2. Characteristics of postal workers with intermediate and full 
adherence to prophylaxis for inhalational anthrax, Washington, D.C., 
2001a
Characteristics
Intermediate 
(n=102) n (%)
Full (n=98) 
n (%) RR (95% CI) p value
Sexb
Female  43 (42)  52 (54) 0.8 (0.6, 1.05) n.s
Male  59 (58)  45 (46) Ref  -
Age,b (y)
18–44   34 (33)  16 (16) 2.0 (1.2, 3.4) p<0.05
>45   68 (67)  81 (84) Ref -
Race/ethnicityb
Black  90 (88)  88 (91) 1.0 (0.9, 1.1) n.s.
Other   5 (5)   3 (3) 1.6 (0.4, 6.5) n.s.
White   7 (7)   6 (6) Ref -
Work description at interviewc
Driver  12 (12)   8 (8) 1.4 (0.6, 3.3) n.s.
Government mail  17 (16)  21 (21) 0.8 (0.4, 1.4) n.s.
Administration   7 (7)   6 (6) 1.1 (0.4, 3.2) n.s.
Plant floor  66 (65)  63 (64) Ref -
Worked on sorter or in government mail sectiond
Yes 70 (72) 70 (75) 0.9 (0.8, 1.1) n.s.
No 27 (28) 23 (25) Ref -
Perceived riske
High 58 (57) 60 (61) 0.9 (0.7, 1.2) n.s.
Some 39 (38) 35 (36) 1.1 (0.7, 1.5) n.s.
None  5 (5)  3 (3) Ref -
Adverse effectsf
A lot 20 (20)  9 (9) 2.1 (1.02, 4.4)  p<0.05
Some 54 (53) 48 (49) 1.1 (0.8, 1.4) n.s.
Not at all  28 (27) 41 (42) Ref -
Physical signs of stressg
5–11 signs 37 (36) 28 (29) 1.3 (0.8, 1.9) n.s.
1–4 signs 50 (49) 57 (58) 0.8 (0.6, 1.1) n.s.
0 signs 15 (15) 13 (13) Ref -
Anxietyh
Yes 37 (36) 33 (34) 1.1 (0.7, 1.6) n.s.
No 65 (64) 65 (66) Ref -
Trouble remembering pillsi
Yes 67 (66) 44 (45) 1.5 (1.1, 1.9) p<0.05
No 35 (34) 54 (55) Ref -
Worse work performancej
Yes 16 (16) 15 (15) 1.0 (0.5, 1.9) n.s.
No 86 (84) 83 (85) Ref -
aRR, relative risk; 95% CI, 95% confidence interval; n.s., not statistically significant; ref, 
referent.
bOne missing value for full adherence. 
cWork location during the survey interview, December 18–20, 2001.
dWorked close to these areas for more than half of the normal workdays during exposure 
period of October 12–21, 2001. Responses of  “don’t know” were excluded from analy-
sis (n=13).
ePerceived risk of breathing in Bacillus anthracis spores during exposure period of Octo-
ber 12–21, 2001.
fReported how much side effects affected their lives. 
gPhysical signs of stress included fatigue, headaches, chest pain, rapid heartbeat, 
unplanned changes in weight, less sleep or difficulty sleeping, muscle tremors or 
twitches, difficulty or rapidity in breathing, elevated blood pressure, nausea or vomiting, 
and dizziness or lightheadedness.
hReported they experienced anxiety since anthrax events started. Anxiety was one of 22 
listed physical, emotional, mental, and behavioral signs of stress on our questionnaire.
iReported they sometimes or almost always had trouble remembering their pills.
jReported side effects negatively affected their work performance.BIOTERRORISM-RELATED ANTHRAX
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to speak with public health staff were necessary to clarify
questions, especially as new issues arose. However, some
workers complained that public health staff could not provide
adequate answers to all their questions, such as those related to
the long-term status of viable B. anthracis spores inhaled into
the lung, the long-term effects of extended antimicrobial ther-
apy, environmental sampling results, the need for personal
protective gear, and other occupational health concerns. 
In the questionnaire, 82% of workers reported they wanted
to receive public health information in a variety of formats,
including both orally and written, as well as information from
the media. The questionnaire showed that only 3% of workers
did not participate in oral communication interventions, 2%
did not receive written materials distributed to employees at
the worksite or at their homes, and 21% did not see posted
signs and messages at work.
Discussion
After the first bioterrorism-related anthrax outbreak in the
United States, we rapidly developed and implemented multiple
adherence interventions to prevent inhalational anthrax in
>2,000 DCPDC workers. This was the first time adherence
interventions have been conducted and evaluated in an applied
public health bioterrorism response. Our interventions pro-
moted the message that adherence was essential for the full 60
days of antimicrobial therapy. Further, the interventions were
carried out during the entire 60-day period. Seventy-six per-
cent of postal workers were taking antimicrobial prophylaxis
at the time of the evaluation. Despite differences in assessing
adherence, the adherence found in this study was relatively
high compared with other studies of adherence to short-course
antimicrobial therapy. For example, Ley (15) reported approx-
imately 50% adherence in a review of adherence studies to
short-course antibiotics, and Brookoff (16) reported only 31%
adherence to a 10-day course of doxycycline (n=386) for out-
patient treatment of pelvic inflammatory disease.
Many issues hindered adherence in this anthrax outbreak,
including adverse effects of the antimicrobial prophylaxis,
such as gastrointestinal upset and yeast infection, trouble
remembering to take the pills, perceived risk, anxiety, and
physical signs of stress. Although these factors occurred in the
context of a bioterrorism event, similar adherence obstacles
Table 3. Predictors of intermediate adherence (n=102) compared with 
full adherence  (n=98), Washington, D.C., 2001a
Predictor covariates Adjusted, OR (95% CI) p value
Age 18–44 y 2.2 (1.1, 4.4) p<0.05
Adverse effectsb A lot 2.8 (1.1, 7.4) p<0.05
Some 1.5 (0.8, 2.8) n.s.
Not at all  ref -
Trouble remembering pillsc Yes 2.2 (1.2, 4.1) p<0.05
a OR, odds ratio; 95% CI, 95% confidence interval; n.s., not statistically significant; ref, 
referent.
bReported how much side effects affected their life.
cReported they sometimes or almost always had trouble remembering their pills.
Table 4. Characteristics of postal workers who discontinued or were 
fully adherent to prophylaxis for anthrax, Washington, D.C., 2001a
Characteristics
Discontinued 
(n=45) n (%)
Full adherence
(n=98), n (%) RR (95% CI) p value
Sexb
Female 25 (56) 52 (54) 1.0 (0.7, 1.4) n.s.
Male 20 (44) 45 (46) Ref -
Ageb
18–44 y 25 (56) 16 (16) 3.4 (2.0, 5.7) p<0.05
>45 y 20 (44) 81 (84) Ref -
Race/ethnicityb
Black 36 (80) 88 (91) 0.9 (0.7, 1.04) n.s.
Other  3 (7)  3 (3) 2.2 (0.4, 10.4) n.s.
White  6 (13)  6 (6) Ref -
Work description at interviewc
Driver  6 (13)  8 (8) 1.6 (0.6, 4.4) n.s.
Government mail  3 (7) 21 (21) 0.3 (0.1, 0.99) p<0.05
Administration 12 (27)  6 (6) 4.3 (1.7, 10.9) p<0.05
Plant floor 24 (53) 63 (64) Ref -
Worked on sorter or in government mail sectiond
Yes 18 (43) 70 (75) 0.6 (0.4, 0.8) p<0.05.
No 24 (57) 23 (25) Ref -
Perceived riske
High 16 (35) 60 (61) 0.6 (0.4, 0.9) p<0.05
Some 25 (56) 35 (36) 1.5 (1.1, 2.2) p<0.05
None  4 (9)  3 (3) Ref -
Adverse effectsf
A lot 11 (25)  9 (9) 2.7 (1.2, 6.0)  n.s.
Some  19 (42) 48 (49) 0.9 (0.6, 1.3) n.s.
Not at all  15 (33) 41 (42) Ref -
Physical signs of stressg
5–11 signs  7 (16) 28 (29) 0.5 (0.2, 1.1) n.s.
1–4 signs 29 (64) 57 (58) 1.1 (0.8, 1.4) n.s.
0 signs  9 (20) 13 (13) Ref -
Anxietyh
Yes 17 (38)  33 (34) 1.1 (0.7, 1.8) n.s.
No 28 (62)  65 (66) Ref -
Trouble remembering pillsi
Yes 23 (51)  44 (45) 1.1 (0.8, 1.6)  n.s.
No 22 (49)  54 (55) Ref -
Worse work performancej
Yes  9 (20) 15 (15) 1.3 (0.6, 2.7) n.s.
No 36 (80) 83 (85) Ref -
aRR, relative risk; 95% CI, 95% confidence interval; n.s., not statistically significant.
bOne missing value for full adherence. 
cWork location during the survey interview, December 18–20, 2001.
dWorked close to these areas for more than half of the normal workdays during exposure 
period of October 12–21, 2001. Responses of “don’t know” excluded from analysis 
(n=13).
ePerceived risk of breathing in Bacillus anthracis spores during exposure period of 
October 12–21, 2001.
fReported how much side effects affected their lives. 
gPhysical signs of stress included fatigue, headaches, chest pain, rapid heartbeat, 
unplanned changes in weight, less sleep or difficulty in sleeping, muscle tremors or 
twitches, difficulty or rapidity in breathing, elevated blood pressure, nausea or vomiting, 
and dizziness or lightheadedness.
hReported they experienced anxiety since anthrax events started. Anxiety was one of 22 
listed physical, emotional, mental, and behavioral signs of stress on our questionnaire. 
iReported they sometimes or almost always had trouble remembering their pills.
jReported side effects negatively affected their work performance.Emerging Infectious Diseases  •  Vol. 8, No. 10, October 2002 1143
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have been reported elsewhere (5,7,17,18). Additional issues
complicating adherence among postal workers included the
large number of workers affected, occupational health and
other work-related issues, limited capacity of local depart-
ments of health to undertake a program to promote adherence
for a large number of people in an emergency, and the hysteria
and media coverage associated with this bioterrorism event,
which likely magnified miscommunication and workers’
confusion. 
In developing the intervention protocols, we drew upon
lessons learned from adherence strategies for isoniazid treat-
ment for latent tuberculosis infection and highly active antiret-
roviral therapy for HIV infection. Studies of these strategies
conclude that interventions must be multifaceted, ongoing,
flexible, individualized, and repetitive to achieve optimal
adherence levels (5,8,9,18–20). Our interventions included
many of these characteristics, such as repeated visits, clarify-
ing questions, counseling workers, incorporating pill-taking
into daily routines, and providing workers with as much infor-
mation as possible about anthrax and antimicrobial therapy.
Inhalational anthrax as a disease and bioterrorism-associated
disease are complex issues and relaying this information to
people was difficult. Therefore, multiple formats (verbal, writ-
ten, and graphic) were necessary to effectively communicate
information to workers. 
Many workers mistook signs of stress (e.g., complaints of
fatigue, lack of sexual drive, and increased crying) for adverse
effects of the antimicrobial therapy. Further, the stress associ-
ated with the bioterrorist event magnified the adverse effects
associated with prophylaxis. For some symptoms, distinguish-
ing between adverse effects of stress and those of the antimi-
crobial therapy, such as gastrointestinal upset, was impossible.
Those who worked close to areas where coworkers with inha-
lational anthrax had worked reported more physical signs of
stress, had a higher perceived risk of having breathed in B.
anthracis spores, and were also more likely to have continued
therapy. Those who had anxiety were more likely to have dis-
continued therapy. Published articles report associations
between anxiety or depression and nonadherence (7,17), and
some researchers posit that the inability to cope with anxiety is
the better predictor of nonadherence (17). These findings high-
light the importance of communicating early and repeatedly
the known adverse effects people should expect, and how to
manage all potential effects, including those caused by pro-
phylaxis and stress or anxiety related to bioterrorist events.
Only self-reports were collected to assess adherence in this
evaluation. Several studies suggest that self-reporting overesti-
mates adherence, while reports of nonadherence are usually
valid (5,7). Therefore, our results may have overestimated
adherence, but it is unlikely that we overestimated the number
of persons who discontinued prophylaxis. Data were collected
from a convenience sample and may not be representative of
all DCPDC workers. A March 2002 phone survey among
DCPDC workers (62% response rate) reported similar age,
sex, and race/ethnicity characteristics (21). Because we did not
have a control group who did not receive interventions to pro-
mote adherence, we cannot measure the effectiveness of our
interventions; however, our adherence findings were similar to
those of other studies that were not implemented in the setting
of a bioterrorist emergency response (7,8,11). In addition, the
evaluation was conducted during the holiday season, the busi-
est time of the year for the USPS, and we were permitted to
conduct the questionnaire only with workers on the day shift
(7 a.m.–3 p.m.). The experiences of day-shift workers may be
different from those who work other shifts, although, based on
the qualitative findings carried out with workers from all shifts
and the continual interactions with workers throughout the 60-
day period, these findings likely reflect the experiences of
most DCPDC workers. Last, our evaluation may have been
affected by the general media coverage of the bioterrorism
events.
Nonadherence is common and should be expected in all
settings, especially in a bioterrorism-related context that
involves further challenges and complications to adherence.
Considering the large number of workers who took less than
the recommended regimen, evaluating adherence promotion
interventions during bioterrorist outbreaks is very important.
In emergency settings, adherence programs may overburden
local departments of health because they require ongoing per-
sonal interactions and are labor-intensive when large numbers
of people are affected. Efforts to develop a plan to promote
adherence in the event of a bioterrorism outbreak, which could
be tailored to the situation and implemented immediately, will
aid future public health emergency responses where adherence
Table 5.  Predictors of discontinued therapy (n=45) compared with full 
adherence (n=98), Washington, D.C., 2001a
Predictor covariates Adjusted, OR (95% CI) p value
Age 18-44 y 6.7 (2.6, 17.3) p<0.05
Perceived riskb High 0.1 (0.01, 0.8) p<0.05 
Some 0.4 (0.1, 3.0) n.s.
None ref -
Adverse effectsc A lot 20.4 (3.0, 140.1) p<0.05
Some 1.7 (0.6, 5.1) n.s.
Not at all  ref -
Physical signs of stressd 5-11 signs 0.02 (0.003, 0.2) p<0.05
1-4 signs 0.3 (0.1, 1.1) n.s.
0 signs Ref -
Anxietye Yes 3.5 (1.1, 10.9) p<0.05
aOR, odds ratio; 95% CI, 95% confidence interval; n.s., not statistically significant; ref, 
referent.
bPerceived risk of breathing in B. anthracis spores during exposure period October 12–
21, 2001.
cReported how much side effects affected their life.
dPhysical signs of stress included fatigue, headaches, chest pain, rapid heartbeat, 
unplanned changes in weight, less or difficulty sleeping, muscle tremors or twitches, dif-
ficulty or rapid breathing, elevated blood pressure, nausea or vomiting, and dizziness or 
lightheadedness.
eReported they experienced anxiety since anthrax events started.  Anxiety was one of 22 
listed symptoms of stress on our questionnaire. BIOTERRORISM-RELATED ANTHRAX
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to recommended prophylaxis is necessary to save lives. Dur-
ing occupational exposures, supplementing occupational
health resources may be necessary. To optimally promote
adherence, such plans should incorporate continual interaction
with the affected persons, provide consistent and clear mes-
sages, and include interventions that help persons incorporate
pill-taking into daily routines and manage known adverse
effects, including those caused by prophylaxis, anxiety, and
stress related to bioterrorism events. 
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